Components of protein synthesis and muscle protein degradation pathways

The phrase "components of protein synthesis and muscle protein degradation pathways" refers to the sets of molecular players and systems involved in the balance between building and breaking down muscle protein. Key synthetic pathways include the IGF-1/PI3K/Akt/mTOR axis, controlling the initiation and efficiency of protein synthesis, with mTOR complex 1 (mTORC1) as a central hub[3][5][7]. Key degradative pathways include the ubiquitin–proteasome system (UPS), which targets most intracellular proteins for regulated degradation via E1, E2, and especially E3 ubiquitin ligases such as MuRF1 and Atrogin-1, as well as the autophagy–lysosome system, the calpain system, and caspase pathways[1][2][3][4]. These components are not a single molecular entity but a network of protein complexes and enzymes, and therefore cannot be directly mapped to a single canonical target. Therapeutic approaches for muscle-wasting conditions typically target upstream regulators (e.g., IGF-1, Akt, mTOR) or downstream effectors (e.g., MuRF1, Atrogin-1) rather than the entire category. This entry should be flagged as is_incorrect: true because it refers to multiple molecular pathways and targets, not a single, canonical drug target or receptor. Rather, it names a functional category encompassing numerous distinct proteins, receptors, and enzymes involved in muscle tissue homeostasis[1][2][3][4][5][6][7].